At TheGLP1Guide.com, our goal is to help readers better understand GLP-1 medications and online treatment options by presenting information that is clear, accurate, and transparent.
Because health-related information can influence real decisions, we take care in how content is researched, written, reviewed, and updated. This page explains how we approach editorial integrity so readers understand how and why information is presented on this site.
Our Editorial Principles
All content published on TheGLP1Guide.com is guided by the following principles:
- Accuracy over speed
- Clarity over marketing language
- Transparency over persuasion
- Education over advice
We aim to explain complex topics in a way that is accessible and neutral, without promoting unrealistic expectations or making personal recommendations.
What We Publish
Content on TheGLP1Guide.com focuses on:
- Educational explanations of GLP-1 medications and how they are used
- Overviews of telehealth provider models and program structures
- Pricing frameworks, membership terms, and renewal policies when publicly available
- Safety considerations, eligibility factors, and commonly reported concerns
- General questions readers may want to discuss with a licensed healthcare professional
Our content is designed to help readers understand what exists and how to evaluate options, not to direct them toward a specific medical decision.
What We Do Not Publish
You will not find the following on TheGLP1Guide.com:
- Guaranteed weight loss claims or outcome promises
- Instructions on obtaining prescription medications without proper medical oversight
- Recommendations to bypass licensed healthcare providers
- Hidden sponsorships or undisclosed promotional placements
- Medical advice tailored to individual circumstances
We avoid exaggerated claims, pressure-based language, and unsupported conclusions.
How We Research GLP-1 Information
Articles and guides are created using publicly available and reputable sources, which may include:
- U.S. Food and Drug Administration drug labeling and safety communications
- Peer-reviewed medical and scientific publications
- Published clinical guidelines and consensus statements
- Telehealth provider disclosures and official program materials
- Aggregated user feedback from established third-party platforms
Information is cross-checked where possible, and sources are evaluated for credibility, relevance, and clarity.
How We Review Telehealth Providers
When discussing or comparing GLP-1 telehealth providers, we focus on factors that affect transparency and patient understanding, including:
- Whether care is overseen by licensed healthcare professionals
- Pharmacy sourcing and licensing disclosures
- Clear differentiation between FDA-approved and compounded medications
- Pricing structure, renewals, and cancellation terms
- Communication around risks, side effects, and eligibility
Providers that lack clear disclosures or omit key information may be excluded from comparisons or discussed with appropriate context.
Rankings and Comparisons
Any rankings or comparisons on TheGLP1Guide.com are based on publicly available information and consistent evaluation criteria. Safety disclosures, transparency, and clarity are weighted more heavily than promotions or pricing alone.
We do not accept paid rankings or sponsored placement in comparison lists.
Medical Accuracy and Updates
While content is not written or reviewed by medical professionals, we aim to align explanations with current regulatory guidance and widely accepted clinical understanding.
Pages are reviewed and updated when:
- Regulatory guidance changes
- Provider pricing or disclosures change
- New safety information becomes available
- Repeated user concerns suggest clarification is needed
Update timing may vary depending on the nature of the information.
Compounded GLP-1 Medications
When discussing compounded GLP-1 medications, we clearly state that compounded drugs are not FDA-approved and that quality and safety depend on pharmacy standards and oversight.
Content addressing compounded medications focuses on transparency, regulatory context, and questions readers may want to raise with licensed healthcare providers.
Affiliate Relationships and Independence
Some pages on TheGLP1Guide.com may include affiliate links. If a reader chooses to explore a service through one of these links, we may earn a commission at no additional cost to the reader.
Affiliate relationships do not influence how information is researched, explained, or presented. Content decisions are based on clarity, transparency, and relevance to readers.
Corrections and Feedback
Accuracy matters. If you believe content on TheGLP1Guide.com is outdated, unclear, or incorrect, you are encouraged to contact us with the page URL and a brief explanation.
When a meaningful correction is made, content is updated accordingly to maintain transparency for readers.
Questions About Our Editorial Process
If you have questions about how content is created or reviewed, you can contact us at:
Email: theglp1guide@gmail.com
Website: https://theglp1guide.com